Trademark: 90626273
Word

Status
Registered
Status Code
700
Status Date
Tuesday, July 18, 2023
Serial Number
90626273
Registration Number
7116003
Registration Date
Tuesday, July 18, 2023
Mark Type
2000
Filing Date
Tuesday, April 6, 2021
Published for Opposition
Tuesday, September 28, 2021

Trademark Owner History
Adaptive Phage Therapeutics, Inc. - Original Registrant

Classifications
40 Custom manufacture of bacteriophage therapeutics
5 Human, animal, plant and microorganism biological preparations for use in drug development, disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the fields of medicine, farming, and food preparation; none of the aforementioned goods used in manufacturing
44 Medical testing for diagnostic or treatment purposes in the field of personalized medicine; health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes; clinical and medical laboratory testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine
42 Research and development in the fields of personalized medicine and diagnostics; data mining of healthcare and genetic information in the field of precision medicine and personalized medicine; scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and/or pharmaceuticals; clinical and medical laboratory testing services for medical research purposes in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom assay development; pharmaceutical drug discovery and development services; providing laboratory research services in the field of medical diagnostics and personalized medicine; medical research services; Biotechnology research; providing medical and scientific research information in the field of clinical trials; research and development of vaccines and therapeutics
The mark consists of a design made up of hexagons and lines.

Trademark Events
Jul 18, 2023
Notice Of Registration Confirmation Emailed
Jul 18, 2023
Registered-Principal Register
Jun 10, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 9, 2023
Allowed Principal Register - Sou Accepted
May 10, 2023
Statement Of Use Processing Complete
Apr 20, 2023
Use Amendment Filed
May 8, 2023
Case Assigned To Intent To Use Paralegal
Apr 20, 2023
Teas Statement Of Use Received
Apr 4, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 4, 2023
Teas Change Of Correspondence Received
Apr 4, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 4, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 4, 2023
Teas Change Of Owner Address Received
Nov 18, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 16, 2022
Sou Extension 2 Granted
Nov 16, 2022
Sou Extension 2 Filed
Nov 16, 2022
Teas Extension Received
May 25, 2022
Notice Of Approval Of Extension Request E-Mailed
May 23, 2022
Sou Extension 1 Granted
May 23, 2022
Sou Extension 1 Filed
May 23, 2022
Teas Extension Received
Nov 23, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 28, 2021
Official Gazette Publication Confirmation E-Mailed
Sep 28, 2021
Published For Opposition
Sep 8, 2021
Notification Of Notice Of Publication E-Mailed
Aug 26, 2021
Approved For Pub - Principal Register
Aug 26, 2021
Examiner's Amendment Entered
Aug 26, 2021
Notification Of Examiners Amendment E-Mailed
Aug 26, 2021
Examiners Amendment E-Mailed
Aug 26, 2021
Examiners Amendment -Written
Aug 25, 2021
Assigned To Examiner
Aug 5, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 5, 2021
Teas Change Of Correspondence Received
Aug 5, 2021
Teas Change Of Owner Address Received
Jul 14, 2021
Notice Of Design Search Code E-Mailed
Jul 13, 2021
New Application Office Supplied Data Entered
Apr 9, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24